Utility of perinuclear anti-neutrophil cytoplasmic antibodies (pANCA), anti-saccharomyces cerevisiae (ASCA), and anti-pancreatic antibodies (APA) as serologic markers in a population based cohort of patients with Crohn's disease (CD) and ulcerative colitis (UC).

Sandborn, W; Loftus, E; Colombel, J; Fleming, K; Seibold, F; Homburger, H; Sendid, B; Chapman, R; Tremaine, W; Kaul, D; Harmsen, W; Targan, SR

Journal article

Utility of perinuclear anti-neutrophil cytoplasmic antibodies (pANCA), anti-saccharomyces cerevisiae (ASCA), and anti-pancreatic antibodies (APA) as serologic markers in a population based cohort of patients with Crohn's disease (CD) and ulcerative colitis (UC).

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Sandborn, W., Loftus, E., Colombel, J., Fleming, K., Seibold, F., Homburger, H., Sendid, B., Chapman, R., Tremaine, W., Kaul, D., Harmsen, W., & Targan, S. R. (2000). Utility of perinuclear anti-neutrophil cytoplasmic antibodies (pANCA), anti-saccharomyces cerevisiae (ASCA), and anti-pancreatic antibodies (APA) as serologic markers in a population based cohort of patients with Crohn's disease (CD) and ulcerative colitis (UC). GASTROENTEROLOGY, 118(4), A106–A106.

MLA Style

Sandborn, W., et al. “Utility of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (PANCA), Anti-Saccharomyces Cerevisiae (ASCA), and Anti-Pancreatic Antibodies (APA) as Serologic Markers in a Population Based Cohort of Patients with Crohn's Disease (CD) and Ulcerative Colitis (UC).” GASTROENTEROLOGY, vol. 118, no. 4, 2000, pp. A106–A106.

Chicago Style

Sandborn, W, E Loftus, J Colombel, K Fleming, F Seibold, H Homburger, B Sendid, et al. 2000. “Utility of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (PANCA), Anti-Saccharomyces Cerevisiae (ASCA), and Anti-Pancreatic Antibodies (APA) as Serologic Markers in a Population Based Cohort of Patients with Crohn's Disease (CD) and Ulcerative Colitis (UC).” GASTROENTEROLOGY 118 (4): A106–A106.
Tweet
Print